相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Noninvasive Determination of IDH and 1p19q Status of Lower-grade Gliomas Using MRI Radiomics: A Systematic Review
A. P. Bhandari et al.
AMERICAN JOURNAL OF NEURORADIOLOGY (2021)
T2-FLAIR Mismatch Sign Is Caused by Long T1 and T2 of IDH-mutant, 1p19q Non-codeleted Astrocytoma
Manabu Kinoshita et al.
MAGNETIC RESONANCE IN MEDICAL SCIENCES (2021)
Real world use of a highly reliable imaging sign: T2-FLAIR mismatch for identification of IDH mutant astrocytomas
Rajan Jain et al.
NEURO-ONCOLOGY (2020)
Clinicopathological analysis of T2-FLAIR mismatch sign in lower-grade gliomas
Shoichi Deguchi et al.
SCIENTIFIC REPORTS (2020)
False-Positive Measurement at 2-Hydroxyglutarate MR Spectroscopy in Isocitrate Dehydrogenase Wild-Type Glioblastoma: A Multifactorial Analysis
Chong Hyun Suh et al.
RADIOLOGY (2019)
Radiographic assessment of contrast enhancement and T2/FLAIR mismatch sign in lower grade gliomas: correlation with molecular groups
Tareq A. Juratli et al.
JOURNAL OF NEURO-ONCOLOGY (2019)
Reclassification of 400 consecutive glioma cases based on the revised 2016WHO classification
Yojiro Akagi et al.
BRAIN TUMOR PATHOLOGY (2018)
The T2-FLAIR mismatch sign as an imaging marker for non-enhancing IDH-mutant, 1p/19q-intact lower-grade glioma: a validation study
Martinus P. G. Broen et al.
NEURO-ONCOLOGY (2018)
T2-FLAIR Mismatch, an Imaging Biomarker for IDH and 1p/19q Status in Lower- grade Gliomas: A TCGA/TCIA Project
Sohil H. Patel et al.
CLINICAL CANCER RESEARCH (2017)
Integration of 2-hydroxyglutarate-proton magnetic resonance spectroscopy into clinical practice for disease monitoring in isocitrate dehydrogenase-mutant glioma
Macarena I. de la Fuente et al.
NEURO-ONCOLOGY (2016)
In-Vivo Proton Magnetic Resonance Spectroscopy of 2-Hydroxyglutarate in Isocitrate Dehydrogenase-Mutated Gliomas: A Technical Review for Neuroradiologists
Hyeonjin Kim et al.
KOREAN JOURNAL OF RADIOLOGY (2016)
Glioma Groups Based on 1p/19q, IDH, and TERT Promoter Mutations in Tumors
Jeanette E. Eckel-Passow et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
IDH mutation status is associated with a distinct hypoxia/angiogenesis transcriptome signature which is non-invasively predictable with rCBV imaging in human glioma
Philipp Kickingereder et al.
SCIENTIFIC REPORTS (2015)
ATRX and IDH1-R132H immunohistochemistry with subsequent copy number analysis and IDH sequencing as a basis for an integrated diagnostic approach for adult astrocytoma, oligodendroglioma and glioblastoma
David E. Reuss et al.
ACTA NEUROPATHOLOGICA (2015)
IDH1 Mutations Are Early Events in the Development of Astrocytomas and Oligodendrogliomas
Takuya Watanabe et al.
AMERICAN JOURNAL OF PATHOLOGY (2009)
IDH1 mutations are present in the majority of common adult gliomas but rare in primary glioblastomas
Koichi Ichimura et al.
NEURO-ONCOLOGY (2009)
An integrated genomic analysis of human glioblastoma Multiforme
D. Williams Parsons et al.
SCIENCE (2008)
Temozolomide for low-grade gliomas - Predictive impact of 1p/19q loss on response and outcome
G. Kaloshi et al.
NEUROLOGY (2007)
Novel method for rapid, simultaneous T1, T2*, and proton density quantification
J. B. M. Warntjes et al.
MAGNETIC RESONANCE IN MEDICINE (2007)
分享论文
